STRA6 Expression Serves as a Prognostic Biomarker of Gastric Cancer

Conclusion: Patients with high levels of STRA6 mRNA experienced significantly worse clinical outcomes, indicating that STRA6 may serve as a diagnostic and prognostic biomarker of GC.

Source: Cancer Genomics and Proteomics - August 27, 2020 Category: Cancer & Oncology Authors: NAKAMURA, S., KANDA, M., SHIMIZU, D., SAWAKI, K., TANAKA, C., HATTORI, N., HAYASHI, M., YAMADA, S., NAKAYAMA, G., OMAE, K., KOIKE, M., KODERA, Y. Tags: Experimental Studies Source Type: research